Novavax announced H1N1 VLP on April 14

feeler · 05-05-2009, 12:23 AM

The first death from swine flu occurred on April 13, when a diabetic woman from Oaxaca died from respiratory complications.

The following day, April 14, Novavax announced:

Novavax, Inc. reported preclinical study results showing that an investigational H1N1 virus-like particle (VLP) vaccine based on the 1918 Spanish influenza strain protected against both the Spanish flu and a highly pathogenic H5N1 avian influenza strain.

PDF format available at Novavax.com:
http://www.novavax.com/download/rele...14_09%20FO.pdf

-feeler

05-05-2009, 12:23 AM	#1
feeler Avalon Senior Member Join Date: Sep 2008 Posts: 360	Novavax announced H1N1 VLP on April 14 The first death from swine flu occurred on April 13, when a diabetic woman from Oaxaca died from respiratory complications. The following day, April 14, Novavax announced: Novavax, Inc. reported preclinical study results showing that an investigational H1N1 virus-like particle (VLP) vaccine based on the 1918 Spanish influenza strain protected against both the Spanish flu and a highly pathogenic H5N1 avian influenza strain. PDF format available at Novavax.com: http://www.novavax.com/download/rele...14_09%20FO.pdf -feeler